Molecular Mechanisms of Kaposi Sarcoma Development

by Andy Karabajakian, Isabelle Ray-Coquard, Jean-Yves Blay
Published 2022-04-01

What underlies the observed hospital volume-outcome relationship?

by Marius Huguet, Xavier Joutard, Isabelle Ray-Coquard, Lionel Perrier
Published 2022-01-01

Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?

by Ana Oaknin, Isabelle Ray-Coquard, Domenica Lorusso, Susana Banerjee
Published 2020-10-01

Territory as cancers inequalities generator

by Yohan Fayet, Virginie Chasles, Françoise Ducimetière, Pr Isabelle Ray-Coquard
Published 2018-01-01

Le territoire, générateur d’inégalités face aux cancers

by Yohan Fayet, Virginie Chasles, Françoise Ducimetière, Pr Isabelle Ray-Coquard
Published 2018-01-01

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

by Isabelle Ray-Coquard, Hélène Vanacker, Olivia Le Saux, Olivier Tredan
Published 2020-11-01

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

by Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, Christophe Caux
Published 2019-03-01

BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges

by Laetitia Collet, Laetitia Collet, Laetitia Collet, Brunhilde Hanvic, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Olivia Le Saux, Isabelle Ray-Coquard, Isabelle Ray-Coquard
Published 2024-03-01

Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors

by Alexandra Lainé, Andrea M. Gonzalez-Lopez, Uzma Hasan, Ryotaro Ohkuma, Isabelle Ray-Coquard
Published 2023-03-01

Cancer screening and follow-up in general practice: A French nationwide cross-sectional study

by Marion Lamort-Bouché, Marine Chardon, Nadir Kellou, Isabelle Ray-Coquard, Cyrille Colin, Laurent Letrilliart
Published 2020-12-01

Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond

by Axel de Bernardi, Armelle Dufresne, Florence Mishellany, Jean-Yves Blay, Isabelle Ray-Coquard, Mehdi Brahmi
Published 2022-02-01

Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?

by Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, Antonio González-Martín, Isabelle Ray-Coquard, Robert L. Coleman
Published 2021-11-01

The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways

by Michael J. Birrer, Keiichi Fujiwara, Ana Oaknin, Leslie Randall, Laureen S. Ojalvo, Christian Valencia, Isabelle Ray-Coquard
Published 2022-02-01

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

by Philipp Harter, Ana Oaknin, Isabelle Ray-Coquard, Domenica Lorusso, Kathleen N Moore, Antonio Gonzalez-Martin, Susana Banerjee
Published 2020-12-01

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial

by Michel Fabbro, Pierre-Jean Lamy, Pierre-Jean Lamy, Célia Touraine, Anne Floquet, Isabelle Ray-Coquard, Caroline Mollevi
Published 2024-01-01

Expanding the molecular spectrum of tenosynovial giant cell tumors

by Thibault Gauduchon, Helene Vanacker, Helene Vanacker, Daniel Pissaloux, Philippe Cassier, Armelle Dufresne, Marie Karanian, Alexandra Meurgey, Amine Bouhamama, François Gouin, Isabelle Ray-Coquard, Isabelle Ray-Coquard, Jean-Yves Blay, Jean-Yves Blay, Franck Tirode, Mehdi Brahmi, Mehdi Brahmi
Published 2022-11-01

Correction to: Beyond the map: evidencing the spatial dimension of health inequalities

by Yohan Fayet, Delphine Praud, Béatrice Fervers, Isabelle Ray-Coquard, Jean-Yves Blay, Françoise Ducimetiere, Guy Fagherazzi, Elodie Faure
Published 2021-01-01

Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer

by Fulvio Borella, Marco Mitidieri, Stefano Cosma, Chiara Benedetto, Luca Bertero, Stefano Fucina, Isabelle Ray-Coquard, Annalisa Carapezzi, Domenico Ferraioli
Published 2023-02-01

Development and validation of a bedside score to predict early death in cancer of unknown primary patients.

by Nicolas Penel, Sylvie Negrier, Isabelle Ray-Coquard, Charles Ferte, Patrick Devos, Antoine Hollebecque, Michael B Sawyer, Antoine Adenis, Pascal Seve
Published 2009-08-01

Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia.

by Gerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, Jon Fryzek, Megan Mullins, Lauren C Bylsma, Joseph K Park
Published 2022-01-01